ZHX2 and B-cell non-Hodgkin lymphoma: Furthermore, ZHX2 expression is closely related to the malignancy and poor prognosis of B-cell lymphoma (11, 12), myeloma (8–10), lung cancer (51), and thyroid cancer (7), suggesting that ZHX2 plays an important role in tumorigenesis and cancer development.